2003 Reports

Low molecular weight heparin [.pdf] Should the MUHC use low-molecular-weight heparin in inpatient treatment of deep vein thrombosis with or without pulmonary embolism? Feb. 2003 (Report #5)

Colorectal stents [.pdf] Should the MUHC approve the use of colorectal stents? Feb. 2003 (Report #6)

Capsule Endoscopy [.pdf] Should the MUHC Approve the Video Capsule Endoscopy System in the Diagnosis of Small Bowel Abnormalities? Mar. 2003 (Report #7)

Eprex [.pdf] Eprex and pure red cell aplasia. What should be MUHC policy for hemodialysis patients? Mar. 2003 (Report #8)

Activated Protein C [.pdf] Drotrecogin alfa (activated) in severe sepsis? Informal HTA. April 2003 (Report #9)

Coated Stents in PCI [.pdf] An evaluation of drug eluting (coated) stents for percutaneous coronary interventions;What should their role be at the McGill University Health Centre (MUHC)? July 2003 (Report #10)

ICDs [.pdf] Use of The Implantable Cardiac Defibrillator (ICD) at the MUHC. September 2003 (Report #11)

Esophageal Stents at the MUHC [.pdf] The Use of Self-Expanding Metallic Stents in the Palliation of Dysphagia in Patients with Malignant Esophageal Strictures. September 2003 (Report #12)